Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FRDF7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,822
Award facts
- Contract value 100% obligated
- $16,822.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,822.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 30 tablets of Cabometyx 40 mg, an oncology treatment. The order was placed on October 23, 2025, with an ultimate completion date of October 24, 2025, and carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal pharmaceutical procurement. DMS Pharmaceutical Group serves as the sole awardee with no identified subcontractors on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders positions it as a critical supplier within the federal pharmaceutical supply chain, with demonstrated capability to fulfill diverse and specialized pharmaceutical requirements for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FRDF7?
SPE2DR26FRDF7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26FRDF7 worth?
The government has obligated $16,822 on SPE2DR26FRDF7.
Is contract SPE2DR26FRDF7 an order under another contract?
Yes. SPE2DR26FRDF7 is a delivery order under SPE2DR25D9143, an indefinite delivery contract.
Was contract SPE2DR26FRDF7 competed?
The extent of competition for SPE2DR26FRDF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award